Substituted pteridines for the treatment of inflammatory diseases

US7648988B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Horst Dollinger · Schemmerhofen, DE
• Domnic Martyres · Biberach, DE
• Juergen Mack · Biberach an der Riß, DE
• Peter Nickolaus · Warthausen, DE
• Birgit Jung · Laupheim, DE

Key dates

• Filing date: Feb 14, 2008
• Grant date: Jan 19, 2010
• Expiry date: Feb 14, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described are new pteridine compounds of the formula 1,where the variables are as described herein. The compounds are useful for the treatment of: respiratory or gastrointestinal complaints or diseases; inflammatory diseases of the joints, skin or eyes; diseases of the peripheral or central nervous system; and cancers. Also described are pharmaceutical compositions which contain these compounds.